Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.

Cancer - 1 Jan 2003

Adem Camilo, Reynolds Carol, Soderberg Cheryl L, Slezak Jeffrey M, McDonnell Shannon K, Sebo Thomas J, Schaid Daniel J, Myers Jeffrey L, Sellers Thomas A, Hartmann Lynn C, Jenkins Robert B

Abstract excerpt

BACKGROUND: BRCA1 and BRCA2 alterations are associated with an increased risk of developing breast carcinoma. The authors hypothesized that the progression of breast neoplasia may differ between patients with hereditary disease and patients with nonhereditary disease and that this difference in progression may be visualized by studying the prevalence of precursor lesions and neoplastic lesions. METHODS: The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma, Mucinous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA1 Protein

Share to BRCA2 Protein

Share to Carcinoma, Ductal, Breast

Share to Carcinoma in Situ

Share to Carcinoma, Lobular

Share to Mastectomy

Source

Identifiers

PMID: 12491499
DOI: 10.1002/cncr.11048

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.PMID 12491499Read ↗

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.Semantic proximity Read ↗

Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.Semantic proximity Read ↗

The pathology of familial breast cancer: Clinical and genetic counselling implications of breast cancer pathology.Semantic proximity Read ↗

Spectrum of histopathologic findings in risk-reducing bilateral prophylactic mastectomy in patients with and without BRCA mutations.Semantic proximity Read ↗

High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.Semantic proximity Read ↗

The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.Semantic proximity Read ↗

p53 alteration in morphologically normal/benign breast luminal cells in BRCA carriers with or without history of breast cancer.Semantic proximity Read ↗

Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.Semantic proximity Read ↗

The clinicopathological and MRI features of patients with BRCA1/2 mutations in familial breast cancerSemantic proximity Read ↗

High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers.Semantic proximity Read ↗

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic casesSemantic proximity Read ↗

Histopathology of BRCA1- and BRCA2-associated breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.